Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

282930313233343536

AstraZeneca earnings fall short of forecasts but pipeline offers hope

8th Feb 2024 10:51

(Alliance News) - Shares in AstraZeneca PLC on Thursday fell after fourth quarter results fell short of expectations although analysts believe the long-term outlook remains promising. Read More

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

8th Feb 2024 08:59

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index. Read More

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

8th Feb 2024 08:44

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled. Read More

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

8th Feb 2024 07:50

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings. Read More

AstraZeneca celebrates latest successful trial of acoramidis in Japan

2nd Feb 2024 08:38

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan. Read More

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

2nd Feb 2024 06:22

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines. Read More

UK earnings, trading statements calendar - next 7 days

1st Feb 2024 15:52

Read More

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

29th Jan 2024 08:19

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours. Read More

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

19th Jan 2024 09:28

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH. Read More

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

16th Jan 2024 11:58

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates. Read More

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

16th Jan 2024 09:14

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More

GSK bolsters respiratory pipeline with USD1.4 billion acquisition

9th Jan 2024 11:51

(Alliance News) - GSK PLC's latest acquisition of Aiolos Bio Inc reflects its focus on respiratory diseases, with the latter's key asset potentially offering a chance to differentiate from rivals, Third Bridge noted. Read More

Berenberg hails AstraZeneca's Alexion as "high-value asset"

9th Jan 2024 11:43

(Alliance News) - German bank Berenberg talked up AstraZeneca PLC's Alexion Pharmaceuticals, believing it is still in good shape despite some competitors entering the market. Read More

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

3rd Jan 2024 16:52

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes. Read More

IN BRIEF: Nuformix narrows annual loss as develops drug assets

3rd Jan 2024 10:16

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses. Read More

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

3rd Jan 2024 10:12

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

3rd Jan 2024 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

3rd Jan 2024 08:58

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively. Read More

C4X receives USD11 million from AstraZeneca following NRF2 trials

3rd Jan 2024 08:04

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment. Read More

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

3rd Jan 2024 07:54

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York. Read More

282930313233343536
FTSE 100 Latest
Value10,585.91
Change61.15